Cullinan Therapeutics CGEM
NASDAQ CGEM
$14.53 -0.82 (-5.35%)
As of: Oct 1, 2026 · 3:59 PM EDT

Cullinan Therapeutics (CGEM) Cash from Financing Activities (2020 - 2026)

Updated

Cullinan Therapeutics' Cash from Financing Activities came in at $1.1 million for Q2 2026, up 194.9% from $373,000 a year earlier and up 189.5% from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Cullinan Therapeutics reported Cash from Financing Activities of $2.2 million, down 33.1% year-over-year; for FY2025, it was $1.09 million, down 99.6% from FY2024.

  • Cash from Financing Activities carries a five-year compound annual growth rate of -62.2% (FY2020 to FY2025).
  • Going back by year, Cash from Financing Activities was $266.19 million in FY2024 (+553.2%), $40.75 million in FY2023, -$25.93 million in FY2022 and $268.78 million in FY2021 (+91.8%).
  • The Q2 2026 figure represents the highest quarterly Cash from Financing Activities since Q4 2024.
  • Year-over-year, Cash from Financing Activities increased in two of the last four quarters, with growth averaging 144.5%.
  • The fastest year-over-year change in Cash from Financing Activities over five years came in Q2 2024 (growth of 579.2%), and the weakest in Q2 2025 (a decline of 99.9%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Cullinan Therapeutics 987.71 Mn 987.71 Mn - 1.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.10 Mn
Mar 31, 2026 380,000.00
Dec 31, 2025 715,000.00
Jun 30, 2025 373,000.00
Dec 31, 2024 1.58 Mn
Sep 30, 2024 1.33 Mn
Jun 30, 2024 262.20 Mn
Mar 31, 2024 1.09 Mn
Dec 31, 2023 248,000.00
Sep 30, 2023 112,000.00
Jun 30, 2023 38.60 Mn
Mar 31, 2023 1.79 Mn
Dec 31, 2022 -32.91 Mn
Sep 30, 2022 1.43 Mn
Jun 30, 2022 2.01 Mn
Mar 31, 2022 3.54 Mn
Dec 31, 2021 2.70 Mn
Sep 30, 2021 579,000.00
Jun 30, 2021 923,000.00
Mar 31, 2021 264.58 Mn
API Access

Cullinan Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CGEM&period=max&api_key=YOUR_API_KEY